Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 3, 2010, Pages

  Cox, Linda ^a   Larenas Linnemann, Desiree ^b   Lockey, Richard F ^c   Passalacqua, Giovanni ^d  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Hospital Medica Sur   (Mexico)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

allergic rhinitis; anaphylaxis grading system; asthma; Subcutaneous allergen immunotherapy; systemic reaction grading system

Indexed keywords

ADRENALIN; POLLEN ANTIGEN;

ALLERGIC RHINITIS; ANAPHYLAXIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; INSECT STING; INTRAVENOUS ADMINISTRATION; MEASUREMENT ERROR; PATIENT POSITIONING; PEANUT ALLERGY; PRIORITY JOURNAL; RECUMBENCY; SUBCUTANEOUS ALLERGEN IMMUNOTHERAPY; SYSTOLIC BLOOD PRESSURE;

EID: 77649273303     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.060     Document Type: Article

References (26)

1. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997. Allergy 53 (1998) 1-42
2. Freeman J. Further observations of the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 2 (1911) 814-817
3. Cox L., Li J., Lockey R., and Nelson H. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 120 (2007) S25-S85
4. Leung D.Y., Nicklas R.A., Li J.T., et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 93 (2004) S1-S21
5. Novak N. Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol 7 (2007) 542-546
6. Werfel T., Breuer K., Rueff F., et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61 (2006) 202-205
7. Jacobsen L., Niggemann B., Dreborg S., et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62 (2007) 943-948
8. Purello-D'Ambrosio F., Gangemi S., Merendino R.A., et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not: a retrospective study. Clin Exp Allergy 31 (2001) 1295-1302
9. Durham S.R., Walker S.M., Varga E.M., et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341 (1999) 468-475
10. Bernstein D.I., Wanner M., Borish L., and Liss G.M. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 113 (2004) 1129-1136
11. Lockey R.F., Benedict L.M., Turkeltaub P.C., and Bukantz S.C. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 79 (1987) 660-677
12. Reid M.J., Lockey R.F., Turkeltaub P.C., and Platts-Mills T.A. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 92 (1993) 6-15
13. Sampson H.A., Munoz-Furlong A., Campbell R.L., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
14. Kemp S.F., Lockey R.F., and Simons F.E. Epinephrine: the drug of choice for anaphylaxis: a statement of the World Allergy Organization. Allergy 63 (2008) 1061-1070
15. Bagg A., Chacko T., and Lockey R. Reactions to prick and intradermal skin tests. Ann Allergy Asthma Immunol 102 (2009) 400-402
16. Amin H.S., Liss G.M., and Bernstein D.I. Evaluation of near-fatal reactions to allergen -immunotherapy injections. J Allergy Clin Immunol 117 (2006) 169-175
17. Epstein T.G., Murphy K., and Bernstein D.I. Fatal and Systemic Reactions to Subcutaneous Immunotherapy: ACAAI/AAAAI National Surveillence Study After One Year. Ann Allergy Asthma Immunol 103 (2009) A23
18. Lockey R.F., Turkeltaub P.C., Baird-Warren I.A., et al. The Hymenoptera venom study I, 1979-1982: demographics and history-sting data. J Allergy Clin Immunol 82 (1988) 370-381
19. Position paper: immunotherapy. (EAACI) The European Academy of Allergology and Clinical Immunology. Allergy 48 (1993) 7-35
20. Alvarez-Cuesta E., Bousquet J., Canonica G.W., Durham S.R., Malling H.J., and Valovirta E. Standards for practical allergen-specific immunotherapy. Allergy 61 suppl 82 (2006) 1-20
21. Rank M.A., Oslie C.L., Krogman J.L., Park M.A., and Li J.T. Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors. Allergy Asthma Proc 29 (2008) 400-405
22. Serrano P., Algorta J., Martinez A., Gonzalez-Quevedo T., Velazquez E., and Diaz M. Prospective safety study of immunotherapy administered in a cluster schedule. J Investig Allergol Clin Immunol 14 (2004) 312-319
23. Serrano P., Justicia J.L., Sanchez C., et al. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study. Ann Allergy Asthma Immunol 102 (2009) 247-252
24. Massanari M., Nelson H., Casale T., Busse W., Kianifard F., Geba G., and Zeldin R. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J Allergy Clin Immunol (2010) in press
25. Stewart II G.E., and Lockey R.F. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 90 (1992) 567-578
26. Windom H., and Lockey R. An update on the safety of specific immunotherapy. Curr Opin Allergy Clin Immunol 8 (2008) 571-576